Named Patient Programme

Personalized Access to Unregistered Medicines

At Global Rare Meds, we break barriers—regulatory, logistical, and geographical—to ensure patients receive the medicines they need under the Named Patient Programme, compliant with Indian laws.

Specialty Medications: Legal Access, Lifesaving Impact

  • Supporting patients and healthcare professionals in acquiring medicines not available or registered in India
  • Covered Therapies: Oncology, Hepatology, Neurology, Transplant, Hematology, Immunology, Nephrology
  • Expertise in pharmacovigilance, ABAC compliance, patient confidentiality, and data protection
  • Team of therapy specialists with strong domain expertise and clinical understanding

Rare Disease Medications: Bridging the Hope Gap

  • We aim to change lives by enabling access to treatments for rare diseases
  • Strategic partnerships with global pharma companies focused on orphan drugs and niche therapies
  • Access to treatment for conditions including:
    Duchenne Muscular Dystrophy, Lysosomal Storage Disorders, Organic Acidemias, Urea Cycle Disorders, Acute Intermittent Porphyria, MPS IV A, MPS VI, Hypophosphatasia, PKU, BH4 Deficiency, Batten Disease, and more